Captor Therapeutics S.A. (CTX) — Net Asset Momentum

Latest YoY growth as of December 2024: -6.9%

Captor Therapeutics S.A. (CTX) recorded a net asset momentum of -6.9% as of December 2024, with net assets of zł64.47 Million PLN. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Captor Therapeutics S.A. net assets for net asset value and shareholders' equity analysis.

YoY Momentum

-6.9%
Year-over-year

Current Net Assets

zł64.47 Million
PLN · December 2024

Years of Data

8
2017 – 2024

Country

Poland
WAR

Captor Therapeutics S.A. Net Asset Momentum (2017–2024)

This chart tracks Captor Therapeutics S.A.'s year-over-year net asset growth across 8 annual reporting periods from 2017 to 2024. The most recent momentum reading is -6.9%, with net assets of zł64.47 Million PLN as of December 2024. For live market cap and overall valuation, see how much is Captor Therapeutics S.A. worth.

Annual Net Asset History for Captor Therapeutics S.A. (2017–2024)

The table below shows the complete annual net asset history for Captor Therapeutics S.A. from 2017 to 2024, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Captor Therapeutics S.A. tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Year Net Assets (PLN) Total Assets Total Liabilities YoY Momentum
2024 zł64.47 Million zł87.50 Million zł23.02 Million ▼ -6.9%
2023 zł69.22 Million zł97.29 Million zł28.07 Million ▼ -28.1%
2022 zł96.32 Million zł113.00 Million zł16.68 Million ▼ -22.4%
2021 zł124.20 Million zł143.54 Million zł19.34 Million ▲ +12470.6%
2020 zł-1.00 Million zł25.78 Million zł26.78 Million ▼ -123.5%
2019 zł4.28 Million zł25.30 Million zł21.02 Million ▲ +24.7%
2018 zł3.43 Million zł18.06 Million zł14.63 Million ▲ +2282.6%
2017 zł144.00K zł5.12 Million zł4.98 Million